Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 25, 2025 08:00 ET | Source: DMG Blockchain Solutions Inc.

DMG Blockchain Solutions Reports Third Quarter 2025 Results

VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG”), a vertically integrated blockchain and data...
August 14, 2025 16:30 ET | Source: Beam Global

Beam Global Announces Second Quarter 2025 Operating Results

Beam Global to Release Q2 2025 Operating Results, Conference Call Scheduled for Thursday, August 14, 2025 at 4:30 p.m. ET.
August 13, 2025 16:15 ET | Source: Alvotech

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flows Continued expansion of...
August 13, 2025 09:00 ET | Source: Dogwood Therapeutics, Inc.

Dogwood Therapeutics Reports Second Quarter 2025 Financial Results

- Enrollment to-date of 52 patients in the ongoing Halneuron® Phase 2b Trial - - Halneuron® Chemotherapy-Induced Neuropathic Pain (“CINP”) Phase 2b study interim data readout remains on track for Q4...
August 12, 2025 07:00 ET | Source: Broadwind, Inc.

Broadwind Announces Second Quarter 2025 Results

CICERO, Ill., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today...
August 11, 2025 09:15 ET | Source: BioCardia, Inc.

BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results

SUNNYVALE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
August 11, 2025 06:00 ET | Source: Beam Global

Beam Global to Release Q2 2025 Operating Results, Conference Call Scheduled for August 14, 2025 at 4:30 p.m. ET

Beam Global to Release Q2 2025 Operating Results, Conference Call Scheduled for Thursday, August 14, 2025 at 4:30 p.m. ET.
August 06, 2025 15:18 ET | Source: BioCardia, Inc.

BioCardia to Host Q2 2025 Corporate Update and Financial Results Conference Call on August 11, 2025

SUNNYVALE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
August 06, 2025 09:15 ET | Source: Dogwood Therapeutics, Inc.

Dogwood Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

ATLANTA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development‐stage biotechnology company developing new medicines to treat pain and...
August 06, 2025 08:00 ET | Source: Alvotech

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT

REYKJAVIK, Iceland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients...